DMXB-A

DRUG2 trials

Sponsors

CoMentis, University of Colorado, Denver

Conditions

Alzheimer DiseaseObesity

Phase 1

Nicotinic Agonist Effects on BMI and Neuronal Response

CompletedNCT02458313

University of Colorado, DenverObesity

Start: 2016-04-14End: 2021-12-13Updated: 2023-06-12

Phase 2

GTS21-201 for Alzheimer Disease:GTS-21 Administered Daily for 28 Days to Participants With Probable Alzheimer's Disease

CompletedNCT00414622

CoMentisAlzheimer Disease

Start: 2006-11-30End: 2007-04-30Target: 60Updated: 2007-04-19